Answers are grounded in this paper and cite their sources.
Adipocytes are increasingly recognized as active signaling hubs within the ovarian cancer tumor microenvironment; whether these adipocyte-derived signals involve tumor-specific long non-coding RNA (lncRNA) programs remains an area poorly investigated. We hypothesized that adipocyte-derived cues induce context-dependent lncRNA regulatory networks in genetically distinct high-grade serous ovarian cancer (HGSOC) cells. To test this, differentiated human adipocytes were used to generate adipocyte-conditioned medium (ACM), which was applied to three genetically distinct HGSOC cell lines prior to targeted profiling of 86 cancer-associated lncRNAs. ACM exposure elicited distinct lncRNA signatures across the three models, with CCAT1 predominating in OVCAR4 cells, H19 in Kuramochi cells, and broader transcriptional remodeling in TYKnu cells, including induction of LSINCT5, GACAT1, and LINC00887. Despite this marked heterogeneity, LINC00887 emerged as the only lncRNA consistently induced across all three HGSOC models, suggesting the presence of conserved adaptive regulatory nodes within otherwise context-dependent transcriptional programs. Functional annotation associated LINC00887 with metabolic and stress-adaptation pathways, while analyses of public ovarian cancer datasets demonstrated increased LINC00887 expression and associations with adverse clinical outcomes. Collectively, these findings support a hierarchical model in which adipocyte-derived signals are decoded through context-dependent lncRNA networks that converge on conserved adaptive programs. This framework provides new insight into adipocyte-tumor communication and identifies LINC00887 as a clinically relevant adipocyte-responsive lncRNA linking metabolic plasticity with ovarian cancer progression.
No takes yet. Share an insight, caveat, or question.
Ha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: